Molecules (May 2024)

Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification

  • Chunsheng Lin,
  • Qianqian Tian,
  • Sifan Guo,
  • Dandan Xie,
  • Ying Cai,
  • Zhibo Wang,
  • Hang Chu,
  • Shi Qiu,
  • Songqi Tang,
  • Aihua Zhang

DOI
https://doi.org/10.3390/molecules29102198
Journal volume & issue
Vol. 29, no. 10
p. 2198

Abstract

Read online

As links between genotype and phenotype, small-molecule metabolites are attractive biomarkers for disease diagnosis, prognosis, classification, drug screening and treatment, insight into understanding disease pathology and identifying potential targets. Metabolomics technology is crucial for discovering targets of small-molecule metabolites involved in disease phenotype. Mass spectrometry-based metabolomics has implemented in applications in various fields including target discovery, explanation of disease mechanisms and compound screening. It is used to analyze the physiological or pathological states of the organism by investigating the changes in endogenous small-molecule metabolites and associated metabolism from complex metabolic pathways in biological samples. The present review provides a critical update of high-throughput functional metabolomics techniques and diverse applications, and recommends the use of mass spectrometry-based metabolomics for discovering small-molecule metabolite signatures that provide valuable insights into metabolic targets. We also recommend using mass spectrometry-based metabolomics as a powerful tool for identifying and understanding metabolic patterns, metabolic targets and for efficacy evaluation of herbal medicine.

Keywords